References
- Kattamis A, Forni GL, Aydinok Y, et al. Changing patterns in the epidemiology of beta-thalassemia. Eur J Haematol. 2020;105:692–703.
- Thein SL. Molecular basis of beta thalassemia and potential therapeutic targets. Blood Cells Mol Dis. 2018;70:54–65.
- Origa R, Sollaino MC, Borgna-Pignatti C, et al. α-globin gene quadruplication and heterozygous β-thalassemia: a not so rare cause of thalassemia intermedia. Acta Haematol. 2014;131:162–164.
- Rivella S. beta-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies. Haematologica. 2015;100:418–430.
- Rivella S. The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia. Blood Rev. 2012;26:S12–S15.
- Alsayegh K, Cortés-Medina LV, Ramos-Mandujano G, et al. Hematopoietic differentiation of human pluripotent stem cells: HOX and GATA transcription factors as master regulators. Curr Genomics. 2019;20:438–452.
- Luo Z, Rhie SK, Farnham PJ. The enigmatic HOX genes: can we crack their code. Cancers (Basel). 2019:323;11:323.
- Ramos-Mejía V, Navarro-Montero O, Ayllón V, et al. HoxA9 promotes hematopoietic commitment of human embryonic stem cells. Blood. 2014;124:3065–3075.
- Yang D, Zhang X, Dong Y, et al. Enforced expression of HoxA5 in haematopoietic stem cells leads to aberrant erythropoiesis in vivo. Cell Cycle. 2015;14:612–620.
- Ozment CP, Turi JL. Iron overload following red blood cell transfusion and its impact on disease severity. Biochim Biophys Acta. - 2009;1790:694–701.
- Shah FT, Sayani F, Trompeter S, et al. Challenges of blood transfusions in beta-thalassemia. Blood Rev. 2019;37:100588.
- Argiropoulos B, Humphries RK. HOX genes in hematopoiesis and leukemogenesis. Oncogene. 2007;26:6766–6776.
- Pezzani L, Milani D, Manzoni F, et al. HOXA genes cluster: clinical implications of the smallest deletion. Ital J Pediatr. 2015;41:31.
- Hess JL, Bittner CB, Zeisig DT, et al. c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. Blood. 2006;108:297–304.
- Mendes A, Jühlen R, Bousbata S, et al. Disclosing the interactome of leukemogenic NUP98-HoxA9 and SET-NUP214 fusion proteins using a proteomic approach. Cells. 2020;10;9: 1666.
- Thorsteinsdottir U, Mamo A, Kroon E, et al. Overexpression of the myeloid leukemia-associated HoxA9 gene in bone marrow cells induces stem cell expansion. Blood. 2002;99:121–129.
- Ordóñez-Morán P, Dafflon C, Imajo M, et al. HoxA5 counteracts stem cell traits by inhibiting WNT signaling in colorectal cancer. Cancer Cell. 2015;28:815–829.
- Crooks GM, Fuller J, Petersen D, et al. Constitutive HoxA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors. Blood. 1999;94:519–528.